SCHEMBL19847534

SCHEMBL19847534

Nc1cccc(-c2ccc3c(c2)Cc2ccccc2-3)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.68
▸ NPC1 O15118 1/20 0.68
▸ ALDH1A1 P00352 1/20 0.68
▸ LMNA P02545 1/20 0.68
▸ MAPT P10636 1/20 0.68
▸ HPGD P15428 1/20 0.68
▸ RAB9A P51151 1/20 0.68
▸ SMN1; SMN2 Q16637 1/20 0.68
▸ TDP2 O95551 2/20 0.57
▸ MAOA P21397 1/20 0.52
▸ CNR1 P21554 1/20 0.48
▸ POLB P06746 1/20 0.45
▸ SRD5A2 P31213 1/20 0.44
▸ PRF1 P14222 1/20 0.43
▸ MAP4K4 O95819 3/20 0.42
▸ MMP12 P39900 1/20 0.42
▸ MMP13 P45452 1/20 0.42
▸ CYP3A4 P08684 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP17A1 P05093 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30469252 1.00 KDM4E (0.68) KDM4ENPC1ALDH1A1LMNAMAPT
SCHEMBL31265899 0.93 TDP2 (0.64) KDM4ENPC1ALDH1A1LMNAMAPT
SCHEMBL30395577 0.85 ALDH1A1 (0.63) KDM4ENPC1ALDH1A1LMNAMAPT
SCHEMBL3414807 0.85 ALDH1A1 (0.63) KDM4ENPC1ALDH1A1LMNAMAPT
SCHEMBL30172496 0.83 MAPT (0.57) KDM4ENPC1ALDH1A1LMNAMAPT
SCHEMBL1666630 0.83 MAPT (0.57) KDM4ENPC1ALDH1A1LMNAMAPT
SCHEMBL1482804 0.83 MAPT (0.57) KDM4ENPC1ALDH1A1LMNAMAPT
SCHEMBL19673668 0.83 RAB9A (0.62) KDM4ENPC1ALDH1A1LMNAMAPT
SCHEMBL19847551 0.82 LMNA (0.67) KDM4ENPC1ALDH1A1LMNAMAPT
SCHEMBL23989284 0.81 RAB9A (1.00) KDM4ENPC1ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12358869-B2 Diarylureas as CB1 allosteric modulators RESEARCH TRIANGLE INSTITUTE 2025-07-15 — — US disclosed
US-20210332007-A1 DIARYLUREAS AS CB1 ALLOSTERIC MODULATORS RESEARCH TRIANGLE INSTITUTE 2021-10-28 — — US disclosed
US-11084781-B2 Diarylureas as CB1 allosteric modulators RESEARCH TRIANGLE INSTITUTE (US) 2021-08-10 — — US disclosed
EP-3621951-A1 DIARYLUREAS AS CB1 ALLOSTERIC MODULATORS Research Triangle Institute (US) 2020-03-18 — — EP disclosed
US-20200062699-A1 DIARYLUREAS AS CB1 ALLOSTERIC MODULATORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2020-02-27 — — US disclosed
WO-2018209030-A1 DIARYLUREAS AS CB1 ALLOSTERIC MODULATORS RTI INTERNATIONAL (US) 2018-11-15 — — WO disclosed
EP-3131901-B1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2018-02-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12358869-B2 Diarylureas as CB1 allosteric modulators CNR1, CNR2, GPR18 KDM4E 1019/4885NPC1 1047/4885ALDH1A1 2918/4885
US-11084781-B2 Diarylureas as CB1 allosteric modulators CNR1, CNR2, GPR18 KDM4E 1019/4885NPC1 1047/4885ALDH1A1 2918/4885
US-20200062699-A1 DIARYLUREAS AS CB1 ALLOSTERIC MODULATORS CNR1, CNR2, GPR18 KDM4E 1019/4885NPC1 1047/4885ALDH1A1 2918/4885
US-20210332007-A1 DIARYLUREAS AS CB1 ALLOSTERIC MODULATORS CNR1, CNR2, GPR18 KDM4E 1019/4885NPC1 1047/4885ALDH1A1 2918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback